United States v. Aziz Kamali, M.D., Inc.

CourtDistrict Court, E.D. California
DecidedDecember 3, 2020
Docket2:20-cv-02156
StatusUnknown

This text of United States v. Aziz Kamali, M.D., Inc. (United States v. Aziz Kamali, M.D., Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Aziz Kamali, M.D., Inc., (E.D. Cal. 2020).

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 FOR THE EASTERN DISTRICT OF CALIFORNIA 10 11 UNITED STATES OF AMERICA, No. 2:20–cv–2156–TLN–CKD 12 Petitioner, FINDINGS AND RECOMMENDATIONS

13 v. (ECF No. 1) 14 AZIZ KAMALI, M.D., INC., and AZIZULAH KAMALI, 15 Respondents. 16

17 18 Presently before the court is the United States’ Petition for Summary Enforcement of a 19 Civil Investigative Demand (“CID”) issued to respondents Azizulah Kamali, M.D., and Aziz 20 Kamali, M.D., Inc., his medical corporation.1 (ECF No. 1.) The petition seeks to compel 21 respondents’ compliance with CID No. 2020-EDCA-11, served in connection with an 22 investigation under the False Claims Act (“FCA”), by providing documents responsive to several 23 production demands, complete answers to interrogatories, and a privilege log. (Id. at 1.) 24 Respondents have not opposed or otherwise responded to the petition.2 Petitioner filed a reply

25 1 This action is before the undersigned pursuant to Eastern District of California Local Rule 302(c)(1). 26 2 In accordance with the court’s October 28, 2020 show cause order, petitioner served 27 respondents both by email and by FedEx overnight delivery with the petition, all accompanying papers, and the court’s show cause order. Respondents’ counsel confirmed receipt of the filings 28 on October 29, 2020, but no further communication followed. (ECF No. 7 at 1 n.1; ECF 1 arguing that respondents have thereby conceded all arguments for, and waived any arguments 2 against, the petition’s enforcement. (ECF No. 7.) The petition was taken under submission 3 pursuant to Local Rules 230(c) and 230(g). (ECF No. 9.) Although the undersigned agrees that 4 respondents’ failure to file any opposition should be construed as a statement of their non- 5 opposition, see L.R. 230(c), the court briefly addresses the merits of the petition—and 6 recommends that the petition be GRANTED. 7 BACKGROUND 8 Respondent Dr. Azizulah Kamali is an internal and geriatric medicine physician practicing 9 in Stockton, California. As part of his practice, Dr. Kamali offers “auricular electro-acupuncture” 10 using a battery-operated device that provides intermittent electrical stimulation to the inside of a 11 patient’s ear. (ECF No. 2 at 1-2.) The United States is investigating whether Dr. Kamali and his 12 medical corporation violated the FCA—specifically 31 U.S.C. § 3729—by knowingly submitting 13 false claims to federal healthcare insurers like Medicare and Medi-Cal for such services. 14 Specifically, the United States is investigating whether respondents’ more than $2.4 million in 15 claims for surgically implanted neurostimulators (which are reimbursed by Medicare at high 16 rates) were fraudulently submitted for the auricular electro-acupuncture services which are not 17 reimbursable under the federal programs. (Id.; ECF No. 3.1 at 2.) 18 On June 12, 2020, as part of this investigation, the United States Attorney for the Eastern 19 District of California—a designee of the United States Attorney General—issued the CID 20 pursuant to the FCA, 31 U.S.C. §§ 3729-3733. (ECF Nos. 3 at 1, 3.1.) On June 16, 2020, the 21 CID was served on respondents. (ECF No. 3 at 2.) Petitioner granted respondents several 22 extensions of time to respond to the CID, which includes 16 demands for documents and 13 23 interrogatories. (Id.; ECF No. 3.1 at 10-13.) On August 10, 2020, respondents submitted 24 responses and objections to the CID but did not produce documents responsive to all demands, 25 nor did they completely answer all interrogatories. (ECF No. 3 at 2-3; ECF Nos. 3.5-3.8.) 26 Petitioner’s repeated attempts over two months to meet and confer with respondents to resolve the 27

28 Nos. 8-8.3.) 1 issues were met with silence from respondents’ counsel. (ECF No. 3 at 3, ECF Nos. 9-10.) 2 Petitioner therefore filed the instant enforcement petition on October 27, 2020, seeking to 3 compel: (1) all responsive documents in response to Demands 1, 2, 4-8, 10-13, and 16; 4 (2) answers to Interrogatories 3 and 4; (3) complete answers to Interrogatories 1, 5-10, and 12; 5 and (4) a privilege log in accordance with Instructions 8 and 9 of the CID. (ECF No. 1.) 6 LEGAL STANDARD 7 “The FCA . . . is the government’s primary litigative tool for combatting fraud against the 8 federal government.” United States ex rel. Kelly v. Boeing Co., 9 F.3d 743, 745 (9th Cir. 1993). 9 “Whenever the Attorney General, or a designee . . . has reason to believe that any person may be 10 in possession, custody, or control of any documentary material or information relevant to a false 11 claims law investigation, the Attorney General, or a designee, may, before commencing a civil 12 proceeding . . . , issue in writing and cause to be served upon such person, a civil investigative 13 demand requiring such person —(A) to produce such documentary material for inspection and 14 copying, [and] (B) to answer in writing written interrogatories with respect to such documentary 15 material or information . . . .” 31 U.S.C. § 3733(a)(1)(A)-(B). 16 “Whenever any person fails to comply with any civil investigative demand issued under 17 subsection (a) . . . , the Attorney General may file, in the district court of the United States for any 18 judicial district in which such person resides, is found, or transacts business, and serve upon such 19 person a petition for an order of such court for the enforcement of the civil investigative demand.” 20 31 U.S.C. § 3733(j)(1). 21 Civil investigative demands are enforced as administrative subpoenas. See United States 22 v. Picetti, No. 2:19-cv-00049-KJM-AC, 2019 WL 1895057, at *2 (E.D. Cal. Apr. 29, 2019) 23 (collecting cases). And as such, the scope of judicial review is “quite narrow.” See United States 24 v. Golden Valley Elec. Ass’n, 689 F.3d 1108, 1113 (9th Cir. 2012). As the Ninth Circuit has 25 explained: “The critical questions are: (1) whether Congress has granted the authority to 26 investigate; (2) whether procedural requirements have been followed; and (3) whether the 27 evidence is relevant and material to the investigation.” EEOC v. Fed. Express Corp., 558 F.3d 28 842, 848 (9th Cir. 2009) (quoting EEOC v. Karuk Tribe Hous. Auth., 260 F.3d 1071, 1076 (9th 1 Cir. 2001)). “If these factors are shown by the agency, the subpoena should be enforced unless the 2 party being investigated proves the inquiry is unreasonable because it is overbroad or unduly 3 burdensome.” EEOC v. Children’s Hosp. Med. Ctr. of N. Cal., 719 F.2d 1426, 1428 (9th Cir. 4 1983) (en banc), overruled on other grounds as recognized in Prudential Ins. Co. of Am. v. Lai, 5 42 F.3d 1299 (9th Cir. 1994). 6 DISCUSSION 7 As to the first factor, the present CID falls squarely within § 3733(a)(1)’s grant of 8 authority to seek documentary material and interrogatory answers.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Aziz Kamali, M.D., Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-aziz-kamali-md-inc-caed-2020.